About Us

Management

Henry Smith, Ph.D.

CEO & Chairman of the Board

Dr. Smith has over 40 years of experience in the healthcare industry and has been the founder of several biotech and medical reference laboratories. He has a degree in cancer immunology from the University of Leeds School of Medicine, England, and has retained an active interest in developing cancer tests and cancer immunotherapy.

James Smith, Ph.D.

President

Dr. Smith has over 20 years of experience in regulatory affairs and new product development. He is an expert in all aspects of regulatory affairs, quality and data management systems, supervision of R&D, and with evaluating and registering medical drug and device product lines. Dr. Smith obtained his Ph.D. in pharmacology and toxicology from the University of California, Irvine.

Daniel Thiel

Vice President, Business Development

Mr. Thiel has over 15 years of experience in the biotech industry providing services in business development, fund raising, corporate finance, investor relations, strategic planning, marketing, and public relations for early-stage development companies. Mr. Thiel received his B.S. in business from Miami University in Oxford, Ohio, with a concentration in international business at Universidad de Las Americas in Puebla, Mexico.

Advisory Board

Sarath Kanekal, DVM, Ph.D., DABT

Member Advisory Board & Consultant

Dr. Kanekal is a board-certified regulatory professional and toxicologist with over twenty years of biotech pharmaceutical industry experience. He is a veterinarian and has a Ph.D. in pharmacology and toxicology from the University of California, Davis, and has conducted postdoctoral research at the School of Pharmacy at University of Texas in Austin. He is experienced in regulatory strategy and safety assessment of small molecules and biologics. He has a track record of rapidly moving early-stage drugs into clinical development and was responsible for more than thirty IND/NDA/BLA approvals, including over fifteen cancer pharmaceuticals.

Guru Betageri, Ph.D.

Member Advisory Board

Dr. Betageri is Assistant Dean and Professor of Pharmaceutical Sciences at Western University of Health Sciences. Dr. Betageri’s expertise is in the area of Liposome Drug Delivery systems. He has published more than sixty original research papers and presented over 100 papers at national and international meetings. He is a reviewer for more than twelve pharmaceutical journals and he is also on the editorial board. He is a co-author on the book entitled “Liposome Drug Delivery.” Dr. Betageri is a member of AAPS, CRS, and AACP.

Dr. Betageri is Assistant Dean and Professor of Pharmaceutical Sciences at Western University of Health Sciences. Dr. Betageri’s expertise is in the area of Liposome Drug Delivery systems. He has published more than sixty original research papers and presented over 100 papers at national and international meetings. He is a reviewer for more than twelve pharmaceutical journals and he is also on the editorial board. He is a co-author on the book entitled “Liposome Drug Delivery.” Dr. Betageri is a member of AAPS, CRS, and AACP.

Vincent F. Simmon, Ph.D.

Member Advisory Board

Dr. Simmon has extensive experience managing and growing companies. He has served as Chief Executive Officer and Chief Operating Officer of public and private pharmaceutical companies developing small molecule therapeutics and biologics for the treatment of brain trauma, cancer, and CNS disorders. Dr. Simmon obtained federal, private, and corporate funding for preclinical and clinical research studies and oversaw the commercialization of several lead candidates. Dr. Simmon received his doctorate in molecular and microbiology from Brown University and completed his postdoctoral work at Stanford University.

H. Vernon Roohk, Ph.D.

Member Advisory Board

Dr. Roohk has over thirty years of experience as a biomedical and bioengineering researcher and consultant. He is currently the Principal Scientist (Physiology) at American ImmunoTech and holds an appointment as Associate Clinical Professor in the Department of Surgery at University of California, Irvine Medical Center. He has published his research widely and holds several patents.

© 2020 by NanoSmart Pharmacueticals, Inc.

Terms and Conditions

Privacy Policy